DAVIS, Calif.--(BUSINESS WIRE)--Vitalea Science, Inc today announced it has received a Small Business Innovation Research grant from the NIH, to develop a medical diagnostic test to assess vitamin B12 malabsorption. The simple test intends to replace the Schillings test, the current standard, for assessing vitamin B12 malabsorption. The new test will allow physicians to more conveniently diagnose patients with vitamin B12 absorption problems before anemia, dementia and/or other permanent damage develops.
